These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34951001)

  • 41. Vancomycin ocular delivery systems based on glycerol monooleate reversed hexagonal and reversed cubic liquid crystalline phases.
    Milak S; Chemelli A; Glatter O; Zimmer A
    Eur J Pharm Biopharm; 2019 Jun; 139():279-290. PubMed ID: 31002864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections.
    Nair AB; Shah J; Jacob S; Al-Dhubiab BE; Sreeharsha N; Morsy MA; Gupta S; Attimarad M; Shinu P; Venugopala KN
    PLoS One; 2021; 16(3):e0248857. PubMed ID: 33739996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
    Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
    Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Novel Gel-Forming Solution Based on PEG-DSPE/Solutol HS 15 Mixed Micelles and Gellan Gum for Ophthalmic Delivery of Curcumin.
    Sai N; Dong X; Huang P; You L; Yang C; Liu Y; Wang W; Wu H; Yu Y; Du Y; Leng X; Yin X; Qu C; Ni J
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31878332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of hydroxypropyl-β-cyclodextrin on the ocular bioavailability of dexamethasone from a pH-induced mucoadhesive hydrogel.
    Kesavan K; Kant S; Singh PN; Pandit JK
    Curr Eye Res; 2011 Oct; 36(10):918-29. PubMed ID: 21950697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Nanoparticle-Based Ophthalmic Formulation of Dexamethasone Enhances Corneal Permeability of the Drug and Prolongs Its Corneal Residence Time.
    Nagai N; Nakazawa Y; Ito Y; Kanai K; Okamoto N; Shimomura Y
    Biol Pharm Bull; 2017; 40(7):1055-1062. PubMed ID: 28674248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
    Patel N; Nakrani H; Raval M; Sheth N
    Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Evaluations of Menthol and Propylene Glycol on the Transdermal Delivery System of Dual Drug-Loaded Lyotropic Liquid Crystalline Gels.
    Tian C; Liu L; Xia M; Chu XQ
    AAPS PharmSciTech; 2020 Aug; 21(6):224. PubMed ID: 32749554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Supramolecular nanofibers of dexamethasone derivatives to form hydrogel for topical ocular drug delivery.
    Zhang Z; Yu J; Zhou Y; Zhang R; Song Q; Lei L; Li X
    Colloids Surf B Biointerfaces; 2018 Apr; 164():436-443. PubMed ID: 29438842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hexagonal liquid crystalline system containing cinnamaldehyde for enhancement of skin permeation of sinomenine hydrochloride.
    Chen J; Long W; Dong B; Cao W; Yuhang X; Meng Y; Xiaoqin C
    Pharm Dev Technol; 2022 Jul; 27(6):684-694. PubMed ID: 35880620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels.
    Asasutjarit R; Thanasanchokpibull S; Fuongfuchat A; Veeranondha S
    Int J Pharm; 2011 Jun; 411(1-2):128-35. PubMed ID: 21459137
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release.
    Rupenthal ID; Green CR; Alany RG
    Int J Pharm; 2011 Jun; 411(1-2):69-77. PubMed ID: 21453762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An environmentally safe larvicide against Aedes aegypti based on in situ gelling nanostructured surfactant systems containing an essential oil.
    Ferreira SG; Conceição VS; Gouveia NS; Santos GS; Santos RL; Lira AA; Cavalcanti SC; Sarmento VH; Nunes RS
    J Colloid Interface Sci; 2015 Oct; 456():190-6. PubMed ID: 26125515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Temperature-responsive, Pluronic-g-poly(acrylic acid) copolymers in situ gels for ophthalmic drug delivery: rheology, in vitro drug release, and in vivo resident property.
    Ma WD; Xu H; Nie SF; Pan WS
    Drug Dev Ind Pharm; 2008 Mar; 34(3):258-66. PubMed ID: 18363141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparation of levofloxacin loaded
    Jain P; Jaiswal CP; Mirza MA; Anwer MK; Iqbal Z
    Drug Dev Ind Pharm; 2020 Jan; 46(1):50-56. PubMed ID: 31818154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritation.
    Chen Y; Lu Y; Zhong Y; Wang Q; Wu W; Gao S
    J Drug Target; 2012 Dec; 20(10):856-63. PubMed ID: 23050903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of menthol on ocular drug delivery.
    Xu X; Yu N; Bai Z; Xun Y; Jin D; Li Z; Cui H
    Graefes Arch Clin Exp Ophthalmol; 2011 Oct; 249(10):1503-10. PubMed ID: 21597947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dexamethasone distribution characteristic following controllable continuous sub-tenon drug delivery in rabbit.
    Huang X; Peng M; Yang Y; Duan Y; Li K; Liu S; Ye C; Lin D
    Drug Deliv; 2017 Nov; 24(1):818-824. PubMed ID: 28509581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cubic liquid crystalline nanoparticles: optimization and evaluation for ocular delivery of tropicamide.
    Verma P; Ahuja M
    Drug Deliv; 2016 Oct; 23(8):3043-3054. PubMed ID: 26878398
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In situ gelling systems based on Pluronic F127/Pluronic F68 formulations for ocular drug delivery.
    Al Khateb K; Ozhmukhametova EK; Mussin MN; Seilkhanov SK; Rakhypbekov TK; Lau WM; Khutoryanskiy VV
    Int J Pharm; 2016 Apr; 502(1-2):70-9. PubMed ID: 26899977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.